Cargando…

Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control

Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Malnati, Mauro S., Ugolotti, Elisabetta, Monti, Maria Cristina, Battista, Davide De, Vanni, Irene, Bordo, Domenico, Sironi, Francesca, Larghero, Patrizia, Marco, Eddi Di, Biswas, Priscilla, Poli, Guido, Vicenzi, Elisa, Riva, Agostino, Tarkowski, Maciej, Tambussi, Giuseppe, Nozza, Silvia, Tripodi, Gino, Marras, Francesco, Maria, Andrea De, Pistorio, Angela, Biassoni, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304173/
https://www.ncbi.nlm.nih.gov/pubmed/28211903
http://dx.doi.org/10.1038/srep42470
_version_ 1782506839878926336
author Malnati, Mauro S.
Ugolotti, Elisabetta
Monti, Maria Cristina
Battista, Davide De
Vanni, Irene
Bordo, Domenico
Sironi, Francesca
Larghero, Patrizia
Marco, Eddi Di
Biswas, Priscilla
Poli, Guido
Vicenzi, Elisa
Riva, Agostino
Tarkowski, Maciej
Tambussi, Giuseppe
Nozza, Silvia
Tripodi, Gino
Marras, Francesco
Maria, Andrea De
Pistorio, Angela
Biassoni, Roberto
author_facet Malnati, Mauro S.
Ugolotti, Elisabetta
Monti, Maria Cristina
Battista, Davide De
Vanni, Irene
Bordo, Domenico
Sironi, Francesca
Larghero, Patrizia
Marco, Eddi Di
Biswas, Priscilla
Poli, Guido
Vicenzi, Elisa
Riva, Agostino
Tarkowski, Maciej
Tambussi, Giuseppe
Nozza, Silvia
Tripodi, Gino
Marras, Francesco
Maria, Andrea De
Pistorio, Angela
Biassoni, Roberto
author_sort Malnati, Mauro S.
collection PubMed
description Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia.
format Online
Article
Text
id pubmed-5304173
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53041732017-03-14 Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control Malnati, Mauro S. Ugolotti, Elisabetta Monti, Maria Cristina Battista, Davide De Vanni, Irene Bordo, Domenico Sironi, Francesca Larghero, Patrizia Marco, Eddi Di Biswas, Priscilla Poli, Guido Vicenzi, Elisa Riva, Agostino Tarkowski, Maciej Tambussi, Giuseppe Nozza, Silvia Tripodi, Gino Marras, Francesco Maria, Andrea De Pistorio, Angela Biassoni, Roberto Sci Rep Article Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are regulatory receptors expressed at the surface of NK and CD8+ T-cells that specifically bind HLA-A and -B alleles belonging to the Bw4 supratype and all the -C alleles expressing the C1 or C2 supratype. We here disclose a novel signature associated with the Elite Controller but not with the long-term nonprogressor status concerning 2DS activating KIRs and HLA-C2 alleles insensitive to miRNA148a regulation. Overall, our findings support a crucial role of NK cells in the control of HIV-1 viremia. Nature Publishing Group 2017-02-13 /pmc/articles/PMC5304173/ /pubmed/28211903 http://dx.doi.org/10.1038/srep42470 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Malnati, Mauro S.
Ugolotti, Elisabetta
Monti, Maria Cristina
Battista, Davide De
Vanni, Irene
Bordo, Domenico
Sironi, Francesca
Larghero, Patrizia
Marco, Eddi Di
Biswas, Priscilla
Poli, Guido
Vicenzi, Elisa
Riva, Agostino
Tarkowski, Maciej
Tambussi, Giuseppe
Nozza, Silvia
Tripodi, Gino
Marras, Francesco
Maria, Andrea De
Pistorio, Angela
Biassoni, Roberto
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
title Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
title_full Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
title_fullStr Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
title_full_unstemmed Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
title_short Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
title_sort activating killer immunoglobulin receptors and hla-c: a successful combination providing hiv-1 control
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304173/
https://www.ncbi.nlm.nih.gov/pubmed/28211903
http://dx.doi.org/10.1038/srep42470
work_keys_str_mv AT malnatimauros activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT ugolottielisabetta activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT montimariacristina activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT battistadavidede activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT vanniirene activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT bordodomenico activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT sironifrancesca activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT largheropatrizia activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT marcoeddidi activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT biswaspriscilla activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT poliguido activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT vicenzielisa activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT rivaagostino activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT tarkowskimaciej activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT tambussigiuseppe activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT nozzasilvia activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT tripodigino activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT marrasfrancesco activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT mariaandreade activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT pistorioangela activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control
AT biassoniroberto activatingkillerimmunoglobulinreceptorsandhlacasuccessfulcombinationprovidinghiv1control